 BUFFALO, N.Y., May 24, 2021 GLOBE NEWSWIRE -- 22nd Century Group, Inc. NYSE American: XXII, a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hempcannabis research, today announced that the Company will participate in the following virtual investor conferences in May and June 2021: 